Opening May 4!
Abstract Submission, Registration, and Housing Reservations for iSBTc's 2009 Programs
The 2009 Annual Meeting and Biomarkers Workshop are shaping up to be can't miss programs. Be sure to secure your spot and submit your abstract early! Visit the iSBTc website for the latest information on the 2009 programs.
Beginning May 4, 2009, abstract submission, registration and housing reservations will be accepted through the iSBTc website. Don't delay, make your plans to attend the 24th Annual Meeting and Biomarkers Workshop today! Early registration discounts apply until Sept. 12. Abstract deadline is July 20, 2009.
iSBTc Represented at NHLBI-PACT Meeting
In recognition of iSBTc’s expertise in adoptive immunotherapy, several iSBTc members were invited to participate on the organizing committee for a workshop entitled “Converging Concepts in Cell Therapy” hosted by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) Production Assistance for Cellular Therapies program (PACT). This Workshop was held April 23-24, 2009 in Bethesda, MD and included expert lectures by several iSBTc members including current President, Bernard A. Fox, PhD; Carl H. June, MD; Pawel Kalinski , MD , PhD; Steven A. Rosenberg, MD, PhD; Marianna Sabatino, David Stroncek, MD; and Theresa L. Whiteside, PhD.
The agenda included discussions related to immunological function and behavior of cells; therapeutic properties and clinical application of cell therapy; unique biotechnology-based approaches to product characterization and cell processing; cell trafficking and imaging techniques and treatments involving a select group of cell-based products key aspects. Slide presentations from the workshop as well as additional resources related to GMP facility design and procedures are available at the PACT website (www.pactgroup.net) and through the Related Links section of the iSBTc website.
Renew Your Dues Today
In these times, it is essential to have a network of peers to support your work and advocate for your interests. iSBTc continues to organize and advocate for the best education in the field, collaboration among constituents, and the implementation of timely, cutting-edge translational clinical research in cancer biotherapy. For further support, we've added two new member benefits:
- Searchable online member directory
Search the membership by specialty, disease state, and more! - Electronic Tables of Contents for Journal of Immunotherapy
Receive emails highlighting the contents of upcoming issues.
To renew your dues, click here or contact the iSBTc office at 414-271-2456 / info@isbtc.org. Non-members are encouraged to review the benefits of iSBTc membership and submit an application today.
Upcoming Programs
iSBTc Organized:
- iSBTc-FDA-NCI Workshop on Prognostic and Predictive Immunologic Biomarkers in Cancer
- October 28, 2009 - Washington, D.C. - iSBTc 2009 Annual Meeting
October 29-31, 2009 - Washington, D.C. - iSBTc 2010 Annual Meeting
October 1-4, 2010 - Washington, D.C.
New days/dates! Friday-Monday - I month earlier!
iSBTc Participating:
- Immunotherapy of Cancer Symposium at the European Congress of Immunology
September 16, 2009 - Berlin, Germany
Other Programs of Interest:
- 1st International Workshop in Clinical Cancer Immunotherapy & Translational Research
November 19-21, 2009 - Havana, Cuba
Member Spotlight - NEW!
Kerrington R. Molhoek
Research Associate
University of Virginia
To assist iSBTc members in building relationships and networking with other investigators, iSBTc presents the "Member Spotlight." This section will be included in each issue of E-news and will profile an iSBTc member.
In this issue, we feature Kerrington Molhoek, PhD, Co-Chair of iSBTc's newly established Young Investigator Taskforce which is focused on fostering the development of young scientists within the Society.
What are your research interests?
My research focuses primarily on cell signaling in melanoma.
Specifically, I am interested in examining Receptor Tyrosine Kinase
(RTK) activity and potential autocrine growth factors for melanomas. In
understanding the signaling environment I hope to find ways to target
aberrant signaling in melanomas to inhibit growth and improve methods
of therapy.
How does being a member of iSBTc help you?
It has helped me develop connections with colleagues and collaborators.
Having access to other iSBTc members for reviewing ideas and soliciting
advice has been invaluable. I have had the opportunity to become
involved on multiple levels in iSBTc. As a member, I have access to the
most up-to-date information in the field. Being a participant at the
annual meetings, has allowed me the opportunity to speak about my work
and get valuable feedback from presentations and poster sessions. As a
member of the Young Investigator Task Force, I have had the opportunity
to reinforce the aspects which have made the iSBTc so valuable to me.
Programs for young investigators including special awards, mentoring
assistance, networking opportunities and career development are
extremely important to members of the iSBTc. Travel awards especially
provide an opportunity for young investigators to access the annual
meeting and understand and appreciate membership in iSBTc. Most of all,
I value my membership because iSBTc has always made me feel as if I
were a valuable member, not just a number.
How do you spend your time outside of your professional life?
I love to spend time with my family, to travel and to fish. I am an
avid college football and basketball fan (Go Hoos!). I also enjoy the
opportunity to relax with a good book.
iSBTc Initiatives and Collaborations
In fulfillment of iSBTc's core values of interaction/integration and innovation, several collaborations, partnerships, and initiatives have been undertaken. These initiatives are designed to promote the Society's mission of improving cancer patient outcomes by advancing the development and application of biological therapy and include directed initiatives that are focused on issues of major importance to the field.
To explore these exciting projects, visit the "Initiatives" section of the iSBTc website.